Closed tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Botulinumtoxin Typ A (OBO), ATC M03AX21 für die Zeit 01.12.2024 - 30.11.2026
In EnglishConclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Botulinum toxin Type A (OBO), ATC M03AX21 for the period 01.12.2024 - 30.11.2026
DAK-Gesundheit in Germany invited bids for “Conclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Botulinum toxin Type A (OBO), ATC M03AX21 for…”. Bids closed on 5 October 2026.
The work
Conclusion of a non-exclusive discount agreement for Botulinumtoxin Typ A (ATC M03AX21) for the period 01.12.2024 - 30.11.2026.
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences